课题基金 / 基金详情

Immunological tolerance regulated by the interaction between T cell and antigen-presenting cell

Immunological tolerance regulated by the interaction between T cell and antigen-presenting cell
T 细胞与抗原呈递细胞相互作用调节免疫耐受
批准号:
15390155
负责人:
ISHII Naoto
金额:
$9.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

ISHII Naoto的其他基金

相似基金

相关文献

中文摘要
翻译
在自身免疫、变态反应性和感染性疾病以及移植物抗宿主病等T细胞介导的疾病中,炎症部位存在OX40~+淋巴细胞和OX40配体^+(OX40L)^+细胞。这些观察表明OX40-OX40L相互作用在免疫疾病中发挥重要作用。CD25~+CD_4~+调节性T细胞(Treg)通过控制外周自身反应性T细胞的激活来抑制自身免疫。最近,一些报道显示OX40在小鼠的Treg细胞上优先表达在mRNA和蛋白表达方面。因此,我们研究了OX40-OX40L相互作用是否可能控制Treg细胞的功能,这是预防自身免疫所必需的。我们通过使用OX40L缺乏的小鼠和过度表达OX40L的小鼠发现,当CD25^-CD4^+T细胞暴露在表达OX40L的细胞中时,或者当他们被激动型OX40特异性单抗处理时,CD25^-CD4^+T细胞对Treg介导的抑制变得不敏感。OX40信号也可以在炎症性肠病的实验模型中取消Treg细胞的疾病预防活性,该模型使用表达不同水平OX40L的RAG2缺陷小鼠。因此,这些数据表明,当OX40信号被直接传递到抗原结合的初始T细胞时,它们可以对抗Treg介导的抑制。综上所述,OX40信号直接控制Treg细胞介导的免疫抑制。
英文摘要
The presence of OX40^+ lymphocytes and OX40 ligand^+ (OX40L)^+ cells at the sites of inflammation in T cell-mediated disorders, such as autoimmunity, allergic and infectious diseases, and GVHD is well documented. These observations suggest important roles for OX40-OX40L interactions in immune disorders. CD25^+CD4^+ regulatory T (Treg) cells suppress autoinununity by controlling peripheral self-reactive T cell activation. Recently, several reports have revealed that OX40 is preferentially expressed on Treg cells in terms of mRNA and protein expression in mice. Thus we examined whether OX40-OX40L interaction may control Treg cell function that are essential for preventing autoimmunity.We found by using OX40L-deificient mice and mice overexpressing OX40L that CD25^-CD4^+ T cells became insensitive to Treg-mediated suppression when they were exposed to OX40L-expressing cells, or when they were treated with an agonistic OX40-specific monoclonal antibody. OX40 signaling could also abrogate the disease-preventing activity of Treg cells in an experimental model of inflammatory bowel disease using RAG2-deficient mice that expressed different levels of OX40L. Thus, these data show that OX40 signals can oppose Treg-mediated suppression when they are delivered directly to antigen-engaged naive T cells. Taken together, OX40 signaling directly control Treg-cell-mediated immune suppression.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
Kato, H., Kojima, H., Ishii, N., Hase, H., Imai, Y., Fujibayashi, T., Sugamura, K., Kobata, T.: "Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations"J.Clin.Immunol.. (印刷中). (2004)
Kato, H.、Kojima, H.、Ishii, N.、Hase, H.、Imai, Y.、Fujibayashi, T.、Sugamura, K.、Kobata, T.:“OX40L 对 B 细胞在持久性中的重要作用重复同种免疫后同种抗体的产生“J.Clin.Immunol..(印刷中)。(2004)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanazawa C, Morita E, Yamada M, Ishii N, Miura S, Asao H, Yoshimori T, Sugamura K.: "Effects of deficiencies of STAMs and Hrs, mammalian class E Vps proteins, on receptor downregulation"Biochem.Biophys.Res.Commun.. 309. 848-856 (2003)
Kanazawa C、Morita E、Yamada M、Ishii N、Miura S、Asao H、Yoshimori T、Sugamura K.:“STAM 和 Hrs、哺乳动物 E 类 Vps 蛋白缺陷对受体下调的影响”Biochem.Biophys.Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishii, N., Ndhlovu, L.C., Murata, K., Sato, T., Kamanaka, M., Sugamura, K.: "OX40(CD134)and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses"Eur.J.Immunol.. 33. 2372-2381 (2003)
Ishii, N.、Ndhlovu, L.C.、Murata, K.、Sato, T.、Kamanaka, M.、Sugamura, K.:“OX40 (CD134) 和 OX40 配体相互作用在体内 Th2 反应过程中发挥佐剂作用”Eur。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Roles for TNFR superfamily molecules in regulation of ILC function
    • 批准号:
      16K15508
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      ISHII Naoto
    • 依托单位:
    Identification and analysis of the niches for helper memory T cells
    • 批准号:
      15H04742
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2015
    • 负责人:
      ISHII Naoto
    • 依托单位:
    Development of a novel human leukemia model using humanized mice
    • 批准号:
      24659487
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      ISHII Naoto
    • 依托单位:
    Basic Research for the study and publication of materials in the collection of Mr. Natsuya Mitsuyoshi
    • 批准号:
      23520183
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      ISHII Naoto
    • 依托单位:
    海外基金